How Big is the Recombinant Protein Market | Industry Trends & Forecast 2025

According to 6Wresearch internal database and industry insights, the Global Recombinant Protein Market was valued at USD 7.4 Billion in 2024 and is expected to reach USD 10.5 Billion by 2031, growing at a compound annual growth rate of 5.20% during the forecast period (2025-2031).

The market for recombinant proteins is growing due to increased demand for products across several applications, including biopharmaceutical development, diagnostics, and therapeutics. This market growth is increasing as healthcare challenges related to infectious diseases and vaccines, cancer research, and regenerative medicine use recombinant proteins, and technological advances in protein expression systems.

Growth Factors for Recombinant Protein Market

• Increasing demand for therapeutic proteins for the treatment of cancer, diabetes, and autoimmune disease.
• Increasing application of recombinant proteins in vaccine development and infectious diseases research.
• Rise in use of recombinant proteins for stem cell research and regenerative medicine.
• Improvement in expression systems that improve quantity and quality of the recombinant protein.
• Increasing funding and collaborations in life sciences and biomedical research and development.

Recombinant Protein Market Trends

The recombinant protein market is witnessing notable trends as biopharma companies shift toward animal-free protein production for safety and compliance. Growth factors, cytokines, and enzymes are increasingly desired for explorations of stem cell biology, immunology, and targeted therapeutics.

The recombinant protein market is seeing further trends with the incorporation of automation and high-throughput technologies in protein synthesis. E-commerce distribution platforms are also garnering attention, providing research institutions and laboratories with smarter, more efficient access to extensive volumes of specialized recombinant proteins.

Emerging Developments in the Recombinant Protein Market

The recombinant protein market is seeing developments as companies develop their investment in new protein engineering techniques. There are efforts to design proteins with stability, bioavailability, and therapeutic efficacy. Adoption of single-use bioreactors is also fine-tuning production processes. Recent developments in the recombinant protein market are also seeing applications in precision medicine, with engineered proteins being developed for targeted therapies.

List of Leading Companies in the Recombinant Protein Market

Some of the leading companies include:

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Abcam plc
• Sino Biological Inc.
• Bio-Techne Corporation
• Genscript Biotech Corporation
• Proteintech Group, Inc.
• Enzo Life Sciences, Inc.
• Novoprotein Scientific Inc.
• Abnova Corporation

Frequently Asked Questions About the Market Study (FAQs):